• Profile
Close

Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: A propensity-matched cohort study

Coronary Artery Disease Jan 03, 2018

Vuurmans T, et al. - This study was designed to test the hypothesis that revascularization with either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) leads to progression of renal failure, but improves survival compared with medical therapy in patients with chronic kidney disease (CKD). Findings revealed that progression of renal failure was higher in the first 3 months for CABG, but similar for all groups at 24 months in patients with coronary artery disease (CAD) and CKD who underwent the current practice of CABG, PCI, or are treated with medical therapy. In addition, in those treated with CABG vs PCI or medical therapy, lower 2-year mortality was noted.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay